| Literature DB >> 31909371 |
Kyoung-Bae Kim1, Kijin Kim2, Changsun Kim3, Suh-Jung Kang4, Hyo Jeong Kim5, Seok Yoon6, Yun-A Shin7.
Abstract
BACKGROUND: Numerous researchers have worked to develop treatments for obesity; however, the prevalence of obesity continues to increase in many countries. Moreover, the effects of physical activity and exercise on obesity remain unclear. Therefore, it is necessary to perform a systematic review and meta-analysis to assess the relationship between exercise and obesity using mediator variables such as the mode of exercise.Entities:
Keywords: Body composition; Exercise mode; Lipid profile; Meta-analysis; Obesity
Year: 2019 PMID: 31909371 PMCID: PMC6939705 DOI: 10.7570/jomes.2019.28.4.278
Source DB: PubMed Journal: J Obes Metab Syndr ISSN: 2508-6235
The characteristics of the studies included in the systematic review and meta-analysis
| Author (year) | Group | N | Age (yr) | Exercise type | Frequency (day/wk) | Time (min) | Duration (wk) | Intensity | Diet control |
|---|---|---|---|---|---|---|---|---|---|
| Herring et al. (2017) | EXP | 12 | 44.3±7.9 | Aerobic and resistance training | 3 | 60 | 12, 24 | 64%–77% MHR, 60% 1RM | |
| CON | 12 | 52.4±8.1 | |||||||
|
| |||||||||
| Marcon et al. (2017) | EXP 1 | 22 | 43.4±2.3 | Aerobic and stretching exercise | 2 | 25 | 19 | RPE 2–4 | × |
| EXP 2 | 17 | 50.1±2.8 | Aerobic and stretching exercise | 2 | 25 | 19 | RPE 2–4 | ||
| CON | 18 | 42.5±2.7 | |||||||
|
| |||||||||
| Zhang et al. (2017) | EXP 1 | 73 | 53.2±7.1 | Vigorous/moderate exercise | 150/wk | 12 mo | Vigorous/moderate | × | |
| EXP 2 | 73 | 54.4±7.4 | Moderate exercise | 150/wk | 12 mo | Moderate | × | ||
| CON | 74 | 54±6.8 | × | ||||||
|
| |||||||||
| Ash et al. (2017) | EXP 1 | 6 | 39.7±4.9 | Aerobic exercise | 3 | 45 | 8 | 60% VO2 peak | × |
| EXP 2 | 5 | 43.4±5.3 | Isometric handgrip | 3 | 8 | 8 | 30% MVC | × | |
| CON | 27 | 40.6±2 | |||||||
|
| |||||||||
| Freitas et al. (2017) | EXP | 26 | 45.9±7.7 | Aerobic and resistance training | 2 | 3 mo | 50%–75% VO2 peak | ||
| CON | 25 | 48.5±9.6 | Stretching and breathing | 2 | 3 mo | ||||
|
| |||||||||
| Baillot et al. (2016) | EXP | 8 | 41.4 | Endurance and strength training | 3 | 80 | 12 | ||
| CON | 20 | 43.3 | |||||||
|
| |||||||||
| Nikseresht et al. (2016) | EXP 1 | 12 | Nonlinear resistance training | 3 | 55 | 12 | Very light–very heavy | ||
| EXP 2 | 10 | Aerobic interval training | 3 | 4 min × 4 rep | 12 | 90% HRmax, 65% HRmax | |||
| CON | 11 | ||||||||
|
| |||||||||
| Nunes et al. (2016) | EXP 1 | 10 | 62 | Low volume resistance training | 3 | 16 | 70% 1RM/3 sets | ||
| EXP 2 | 11 | 62 | High volume resistance training | 3 | 16 | 70% 1RM/6 sets | |||
| CON | 11 | 60 | |||||||
|
| |||||||||
| Soori et al. (2017) | EXP 1 | 8 | Water-based endurance training | 3 | 45 | 10 | 40%–60% HRmax | × | |
| EXP 2 | 8 | Resistance training | 3 | 10–12 rep | 10 | 40%–60% 1RM/3 sets | × | ||
| EXP 3 | 8 | Combined training | 3 | 44 | 10 | 40%–60% HRmax, 40%–60% 1RM | × | ||
| CON | 8 | × | |||||||
|
| |||||||||
| Cuthbertson et al. (2016) | EXP | 30 | 50 | Moderately intense aerobic exercise | 3–5 | 30–45 | 16 | 30%–60% HRR | × |
| CON | 20 | 52 | × | ||||||
|
| |||||||||
| Rafraf et al. (2015) | EXP 1 | 11 | 34.8±6.2 | Exercise+carnitine | 3 | 8 | 55%–70% HRmax | × | |
| EXP 2 | 10 | 36.1±7.2 | Exercise+placebo | 3 | 30/30×3 | 8 | 55%–70% HRmax | × | |
| CON 1 | 11 | 34.4±5.5 | Carnitine | × | |||||
| CON 2 | 11 | 36.5±7.3 | Placebo | × | |||||
|
| |||||||||
| Abdelaal and Mohamad (2015) | EXP 1 | 20 | 52.2±3 | Circuit weight training | 3 | 12 | 60%–75% 1RM | × | |
| EXP 2 | 20 | 53±3.5 | Aerobic exercise training | 3 | 20–35/40–50 | 12 | 60%–75% HRmax/RPE 12–14 | × | |
| CON | 19 | 52±3.3 | |||||||
|
| |||||||||
| Arad et al. (2015) | EXP | 9 | High intensity interval training | 3 | 24 | 14 | 75%–90% HRR | ||
| CON | 11 | ||||||||
|
| |||||||||
| Kim et al. (2015) | EXP | 29 | 24.9±2.8 | Aerobic exercise | 4 | 8 | 65%–75% VO2max | × | |
| CON | 10 | 26.6±2.8 | × | ||||||
|
| |||||||||
| Benito et al. (2015) | EXP 1 | 24 | Strength training | 3 | 60 | 22 | 50%–60% 1RM | ||
| EXP 2 | 26 | Endurance training | 3 | 60 | 22 | 50%–60% HRR | |||
| EXP 3 | 24 | Strength+endurance training | 3 | 60 | 22 | 50%–60% 1RM/50%–60% HRR | |||
| CON | 22 | ||||||||
|
| |||||||||
| Kordi et al. (2015) | EXP | 14 | 42.2±14.4 | Abdominal resistance training | 3 | 12 | 2 Sets of 8 reps | ||
| CON | 16 | 43±15.1 | |||||||
|
| |||||||||
| Park et al. (2015) | EXP | 10 | 57.2±2.6 | Aerobic+resistance exercise | 4 | 30–40 | 12 | 40%–75% HRR | × |
| CON | 10 | 57.2±1.7 | |||||||
|
| |||||||||
| Ross et al. (2015) | EXP 1 | 73 | 52.1±7.4 | Low amount, low intensity exercise | 5 | 180–300 kcal | 24 | 50% VO2 peak | × |
| EXP 2 | 76 | 50.9±8.6 | High amount, low intensity exercise | 5 | 300–600 kcal | 24 | 50% VO2 peak | × | |
| EXP 3 | 76 | 50.3±8.1 | High amount, high intensity exercise | 5 | 360–600 kcal | 24 | 75% VO2 peak | × | |
| CON | 75 | 52.2±8.2 | |||||||
|
| |||||||||
| Pugh et al. (2014) | EXP | 34 | 48 | Gymnasium | 3–5 | 30–45 | 12 | 45%–60% HRR | × |
| CON | 20 | 47 | |||||||
|
| |||||||||
| Nikseresht et al. (2014) | EXP 1 | 12 | Nonlinear resistance training | 3 | 40–65 | 12 | Very light–very heavy | × | |
| EXP 2 | 12 | Aerobic interval training | 3 | 16–20 | 12 | 80%–90% HRmax/3 min recovery | × | ||
| CON | 10 | × | |||||||
|
| |||||||||
| Herring et al. (2014) | EXP 1 | 11 | Resistance exercise | 3 | 60 | 12 | 60% 1RM | × | |
| EXP 2 | 12 | Aerobic exercise | 3 | 60 | 12 | 50%–70% HRR | × | ||
| CON | 10 | × | |||||||
|
| |||||||||
| Irving et al. (2009) | EXP 1 | 13 | 49.2±1.8 | Low intensity exercise | 5 | 350–400 kcal | 16 | RPE 10–12 | × |
| EXP 2 | 11 | 49.0±2.9 | High intensity exercise | 5 | 350–400 kcal | 16 | 3 Day RPE 15–17/2 day RPE 10–12 | × | |
| CON | 10 | 49.2±4.8 | × | ||||||
|
| |||||||||
| Straznicky et al. (2010) | EXP | 20 | 54±1 | Bicycle riding | 3 | 40 | 12 | 65% MHR | × |
| CON 1 | 20 | 55±1 | Dietary weight loss | ||||||
| CON 2 | 19 | 55±1 | No treatment | ||||||
|
| |||||||||
| Ibáñez et al. (2010) | EXP 1 | 12 | 51.4±5.5 | Caloric restriction of 500 kcal/day | 3 | 16 | |||
| EXP 2 | 13 | 2 | 45–60 | 16 | 50%–80% 1RM | ||||
| CON | 9 | × | |||||||
|
| |||||||||
| Christiansen et al. (2010) | EXP 1 | 25 | Aerobic exercise | 3 | 60–75 | 12 | × | ||
| CON | 29 | 600 and 800 kcal/day | |||||||
| EXP 2 | 25 | 750–1,000 kcal/day, aerobic exercise | 3 | 60–75 | 12 | ||||
|
| |||||||||
| Sartor et al. (2010) | EXP | 10 | 37±10 | High intensity interval training | 3 | 40 | 2 | 90% VO2 peak | × |
| CON | 9 | 41±14 | × | ||||||
|
| |||||||||
| Plotnikoff et al. (2010) | EXP | 27 | 55±12 | Core and assistance exercise | 3 | 16 | 80% 1RM | × | |
| CON | 21 | 54±12 | × | ||||||
|
| |||||||||
| Yamaguchi et al. (2011) | EXP | 11 | 50.0±3.1 | Treadmill walking | Every day | 2 rep×30 min | 4 | Anaerobic threshold | |
| CON | 8 | 50.0±2.7 | Low calorie diet of 25 kcal/kg | 4 | |||||
|
| |||||||||
| Straznicky et al. (2011) | EXP | 13 | 52±1 | Bicycle riding | 3 | 40 | 12 | 65% MHR | |
| CON 1 | 13 | 55±2 | Reduction of 600 calories | ||||||
| CON 2 | 12 | 56±2 | |||||||
|
| |||||||||
| Lim et al. (2011) | EXP | 99 | 28.0±0.3 | Aerobic, resistance exercise | 7 | 60 | 12 | ||
| CON 1 | 98 | 28.0±0.3 | Metformin, maximum dose of 1,500 mg/day | 12 | |||||
| CON 2 | 100 | 28.0±0.3 | Placebo, maximum dose of 1,500 mg/day | 12 | |||||
|
| |||||||||
| Brinkley et al. (2011) | EXP 1 | 15 | 57.3±5.7 | Treadmill 15–20 min at 45%–50% of HRR during first week/hypocaloric menu/ calcium supplement | 3 | 55 | 20 | 45%–50% HRR | |
| EXP 2 | 8 | 59.4±4.9 | Treadmill 15–20 min at 70%–75% of HRR during first week/hypocaloric menu/ calcium supplement | 3 | 30 | 20 | 70%–75% HRR | ||
| CON | 8 | 57.6±4.8 | Hypocaloric menu lunch & dinner/daily calcium supplement (1,000 mg/day) | 20 | |||||
|
| |||||||||
| Brinkley et al. (2011) | EXP 1 | 22 | 58.5±5.3 | Treadmill | 3 | 20–55 min | 20 | 45%–50% HRR | |
| EXP 2 | 17 | 57.2±4.3 | Treadmill | 3 | 10–30 min | 20 | 70%–75% HRR | ||
| CON | 22 | 58.4±6.2 | Hypocaloric menu/allowed 2 free days per month/calcium supplement 1,000 mg/day | 20 | |||||
|
| |||||||||
| Atashak et al. (2011) | EXP 1 | 8 | 23.6±4.4 | Resistance training protocol | 3 | 10 | 75%–80% 1RM | ||
| EXP 2 | 8 | 23.7±3.8 | Resistance training protocol | 3 | 10 | 75%–80% 1RM | |||
| CON 1 | 8 | 23.6±3.3 | 4 Capsules of ginger rhizome power | 4 times/day | 10 | ||||
| CON 2 | 8 | 25.3±2.2 | 1 g of maltodextrin (placebo) | 10 | × | ||||
|
| |||||||||
| Shah et al. (2011) | EXP | 21 | 47.3±10.0 | Moderate-intensity aerobic exercise | 5 | 12 | 60%–70% VO2max | ||
| CON | 12 | 53.9±8.8 | |||||||
|
| |||||||||
| Castello et al. (2011) | EXP | 11 | 38.4±4.0 | Aerobic training on a treadmill | 3 | 61 | 12 | 70% HRpeak | × |
| CON | 10 | 36±4 | × | ||||||
|
| |||||||||
| You et al. (2011) | EXP 1 | 13 | 57±2 | Treadmill | 3 | 55 | 20 | 45%–50% HRR | |
| EXP 2 | 8 | 62±2 | Treadmill | 3 | 30 | 20 | 70%–75% HRR | ||
| CON | 9 | 59±2 | Hypocaloric menu (RD) & allowed 2 free day/mo & calcium supplement (1,000 mg/day) | 20 | |||||
|
| |||||||||
| Henagan et al. (2011) | EXP | 12 | 65.2±2.6 | Progressive RT | 3 | 12 | 8RM | ||
| CON | 11 | 66.1±3.0 | |||||||
|
| |||||||||
| Lee et al. (2012) | EXP | 8 | 54.8±2.8 | Yoga exercise | 3 | 60 | 16 | × | |
| CON | 8 | 54.3±2.9 | × | ||||||
|
| |||||||||
| Sullivan et al. (2012) | EXP | 12 | 48.6±2.2 | Walking on a motor-driven treadmill | 5 | 30–60 | 16 | 45%–55% VO2max | × |
| CON | 6 | 47.5±3.1 | × | ||||||
|
| |||||||||
| Swift et al. (2012) | EXP 1 | 68 | 57.4±5.4 | Cycle ergometer | 3 | 20 | 4 | Pedal cadence of 50 RPM | × |
| EXP 2 | 32 | 55.9±6.0 | Cycle ergometer | 3 | 20 | 8 | Pedal cadence of 51 RPM | × | |
| EXP 3 | 32 | 56.3±6.8 | Cycle ergometer | 3 | 20 | 12 | Pedal cadence of 52 RPM | ||
| CON | 23 | 56.8±5.4 | |||||||
|
| |||||||||
| Foster-Schubert et al. (2012) | EXP 1 | 117 | 58.1±5.0 | Aerobic exercise | 5 | 45 | 12 mo | 70%–85% HRmax | × |
| EXP 2 | 117 | 58.0±4.5 | Aerobic exercise & caloric restriction | 5 | 45 | 12 mo | 70%–85% HRmax | ||
| CON 1 | 87 | 57.4±4.4 | × | ||||||
| CON 2 | 118 | 58.1±6.0 | Caloric deficit of 500–1,000 kcal/day | ||||||
|
| |||||||||
| Abd El-Kader et al. (2015) | EXP | 39 | 43.6±6.2 | Treadmill aerobic exercise | 3 | 10–30 | 3 mo | 60%–70% HRmax | × |
| CON | 39 | 44.1±5.9 | No exercise training | × | |||||
|
| |||||||||
| Wong et al. (2016) | EXP 1 | 14 | 58±4 | WBVT & intake placebo (4 capsules before breakfast & sleeping) | 3 | 11–60 | 8 | 25–40 Hz | × |
| EXP 2 | 13 | 58±3 | WBVT & intake L-Citrulline | 3 | 11–60 | 8 | 25–40 Hz | ||
| CON | 14 | 58±4 | Intake L-Citrulline (4 capsules before breakfast & sleeping) | ||||||
|
| |||||||||
| Osama and Shehab (2015) | EXP | 50 | 36.4±5.1 | Aerobic training | 3 | 40 | 36 | Moderate | |
| CON | 50 | 37.2±4.3 | 36 | ||||||
|
| |||||||||
| Franklin et al. (2015) | EXP | 10 | 30.3±5.4 | Circuit-based resistance training | 1 | 20 | 8 | 10RM | × |
| CON | 8 | 30.8±9.0 | |||||||
|
| |||||||||
| Coen et al. (2015) | EXP | 66 | 41.3±9.7 | Semi-supervised moderate exercise | 3–5 | 147/ wk | 6 mo | × | |
| CON | 62 | 41.9±10.3 | Health education | ||||||
|
| |||||||||
| Romero Moraleda et al. (2013) | EXP 1 | 24 | 36.1±8.7 | Strength training | 3 | 50–60 | 22 | 50%–60% HRR or 15RM | |
| EXP 2 | 26 | 35.8±8.0 | Endurance training | 3 | 50–60 | 22 | 50%–60% HRR or 15RM | ||
| EXP 3 | 24 | 36.0±7.3 | Strength+endurance training | 3 | 50–60 | 22 | 50%–60% HRR or 15RM | ||
| CON | 22 | 36.8±8.9 | Physical activity | 3 | 50–60 | 22 | 50%–60% HRR or 15RM | ||
|
| |||||||||
| Figueroa et al. (2013) | EXP 1 | 13 | 54±1 | Low-intensity resistance exercise | 3 | 12 | × | ||
| EXP 2 | 14 | 54±1 | Low-intensity resistance exercise | 3 | 12 | ||||
| CON | 14 | 55±1 | 12 | ||||||
|
| |||||||||
| Bhutani et al. (2013) | EXP 1 | 18 | 45±5 | ADF+exercise | 3 | 35–60 | 12 | 60%–75% HRmax | |
| EXP 2 | 24 | 42±2 | 3 | 35–60 | 12 | 60%–75% HRmax | |||
| CON 1 | 25 | 42±2 | Dietary restriction | 12 | Controlled feeding | ||||
| CON 2 | 16 | 49±2 | |||||||
|
| |||||||||
| Figueroa et al. (2013) | EXP 1 | 14 | 54±1 | Supervised exercise session | 3–4 | 40 | 12 | 18–22 Repetitions | × |
| EXP 2 | 14 | 54±1 | Combination | 3–4 | 40 | 12 | 18–22 Repetitions | ||
| CON | 13 | 54±1 | Commercial weight-loss program | 12 | |||||
|
| |||||||||
| Trussardi Fayh et al. (2013) | EXP | 17 | 32.4±7 | Training program | 3 | 30–45 | 12 | 50%–70% HRR | |
| CON | 18 | 30.1±5.5 | |||||||
|
| |||||||||
| García-Unciti et al. (2012) | EXP | 13 | 48.6±6.4 | Resistance training | 2 | 16 | 50%–80% 1RM | ||
| CON 1 | 12 | 51.4±5.5 | 16 | ||||||
| CON 2 | 9 | 50.2±6.8 | |||||||
|
| |||||||||
| Tseng et al. (2013) | EXP 1 | 10 | 22.2±0.7 | 3 Day aerobic, 2 day resistance training | 5 | 60 | 12 | 50%–60% HRR, 60%–70% HRR, 50%–60% 1RM | |
| EXP 2 | 10 | 22.1±1.1 | Aerobic training | 5 | 60 | 12 | 50%–60% HRR, 60%–70% HRR | ||
| EXP 3 | 10 | 21.3±0.6 | Resistance training | 5 | 60 | 12 | 50%–60% 1RM | ||
| CON | 10 | 22.3±1.0 | |||||||
|
| |||||||||
| Fayh et al. (2013) | EXP | 17 | 32.3±6.4 | University gymnasium | 3 | 45 | 65.9 day | 70% HRR | × |
| CON | 18 | 31.4±5.6 | Physical activity | ||||||
|
| |||||||||
| Kim and Kim (2012) | EXP | 15 | 53.5±2.4 | Line dance exercise | 3 | 60 | 16 | HRmax-age% | × |
| CON | 15 | 53.5±2.4 | |||||||
|
| |||||||||
| Snel et al. (2012) | EXP | 13 | 53.0±2.5 | Very low calorie diet+exercise | 1 | 30 | 16 | 70% VO2max | |
| CON | 14 | 56.1±2.4 | Very low calorie diet | 16 | |||||
|
| |||||||||
| Cakmakçi (2011) | EXP | 34 | 36.2±9.6 | Pilates training | 4 | 60 | 8 | 60%–70% HRmax | × |
| CON | 27 | 39.0±10.0 | |||||||
|
| |||||||||
| Masuo et al. (2012) | EXP 1 | 30 | 37±6 | Aerobic exercise or gym exercise | 2 | 60 | 24 | ||
| EXP 2 | 30 | 38±5 | Aerobic exercise or gym exercise | 2 | 60 | 24 | |||
| CON | 30 | 38±5 | Calorie restriction | 24 | |||||
|
| |||||||||
| Kerksick et al. (2010) | EXP 1 | 9 | 43±7 | Diet+exercise (high energy diet) | 1 | 30 | 14 | 60%–80% HRmax | |
| EXP 2 | 5 | 42±2 | No diet+exercise | 2 | 30 | 14 | 60%–80% HRmax | × | |
| EXP 3 | 39 | 38±8 | Very low carbohydrate, high protein diet | 1 | 30 | 14 | 60%–80% HRmax | ||
| EXP 4 | 36 | 40±7 | Low carbohydrate, moderate protein diet | 1 | 30 | 14 | 60%–80% HRmax | ||
| EXP 5 | 43 | 38±8 | High carbohydrate, low protein diet | 1 | 30 | 14 | 60%–80% HRmax | ||
| CON | 9 | 32±10 | No diet+no exercise | 2 | 14 | × | |||
|
| |||||||||
| Kadoglou et al. (2010) | EXP 1 | 22 | 56.9±7.1 | Exercise training | 4 | 60 | 12 mo | 50%–80% VO2 Peak | × |
| EXP 2 | 23 | 57.8±7.6 | Therapy+exercise training | 4 | 60 | 12 mo | 50%–80% VO2 Peak | × | |
| CON | 21 | 60.3±9.3 | Maintenance | 12 mo | × | ||||
| RSG | 23 | 59.0±7.4 | Add -on therapy with rosiglitazone | 7 | 12 mo | × | |||
|
| |||||||||
| Murakami et al. (2007) | EXP | 24 | 51.0±2.1 | Diet+exercise | 3 | 60 | 12 | RPM 12–14 | |
| CON | 18 | 48.2±1.9 | Diet | 12 | |||||
|
| |||||||||
| Arslan (2011) | EXP | 29 | 41.6±6.7 | Step-aerobic dance | 3 | 60 | 8 | 50%–85% VO2max | × |
| CON | 20 | 37.0±9.1 | × | ||||||
|
| |||||||||
| Mezghanni et al. (2014) | EXP 1 | 11 | 27±4 | Moderate intensity training | 5 | 60 | 12 | 50% HRR | × |
| EXP 2 | 10 | 25±5 | High intensity training | 5 | 60 | 12 | 75% HRR | × | |
| EXP 3 | 12 | 28±5 | Alternate intensity training | 5 | 60 | 12 | 50%–75% HRR | × | |
| CON | 10 | 25±4 | |||||||
|
| |||||||||
| Rshikesan and Subramanya (2016) | EXP | 37 | 40.0±8.7 | Special yoga training (IAYT) | 5 | 90 | 14 | × | |
| CON | 35 | 42.2±12.1 | Regular physical activities | ||||||
Values are presented as mean±standard deviation.
EXP, experimental group; CON, control group; MHR, maximal heart rate; RM, repetition maximum; RPE, rated perceived exertion; VO2 peak, peak oxygen uptake; MVC, maximum voluntary contraction; rep, repetition; HRmax, maximal heart rate; HRR, heart rate reserve; RD, registered dietitian; RT, resistance training; WBVT, whole-body vibration training; ADF, alternate day fasting; IAYT, integrated approach of yoga therapy.
Effect size of exercise interventions on body composition and lipid profiles
| Factor | Study (n) | Subject (n) | SMD (95% CI) | I2 (%) | |
|---|---|---|---|---|---|
| Weight (kg) | 89 | 3,665 | 0.358 (0.213 to 0.503) | <0.001 | 75.9 |
| BMI (kg/m2) | 78 | 3,682 | 0.533 (0.349 to 0.716) | <0.001 | 84.8 |
| Body fat (%) | 47 | 2,049 | 0.379 (0.246 to 0.512) | <0.001 | 44.3 |
| Waist circumference (cm) | 75 | 3,516 | 0.666 (0.478 to 0.854) | <0.001 | 84.1 |
| TC (mg/dL) | 35 | 906 | 0.721 (0.228 to 1.214) | 0.004 | 94.5 |
| TG (mg/dL) | 56 | 2,226 | 0.603 (0.257 to 0.949) | <0.001 | 92.2 |
| LDL (mg/dL) | 49 | 1,994 | 0.406 (0.238 to 0.573) | <0.001 | 65.3 |
| HDL (mg/dL) | 57 | 2,270 | −0.222 (−0.495 to 0.052) | 0.112 | 88.7 |
SMD, standardized mean difference; CI, confidence interval; BMI, body mass index; TC, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
Figure 1Forest plot of % body fat. The meta-analysis result of % body fat is presented because only % body fat met both the statistical significance and heterogeneity criteria (I2 <50%). “Total” in the figure indicates the number of subjects. Thirteen articles had several (2–5 pieces) comparisons, and each comparison was presented independently in the plot. SD, standard deviation; SMD, standardized mean difference; CI, confidence interval.
Meta-ANOVA results for moderator effects on body composition
| Moderator | Weight | BMI | % Body fat | Waist circumference | ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
| SMD (95% CI) | n | SMD (95% CI) | n | SMD (95% CI) | n | SMD (95% CI) | n | |
| Diet control | ||||||||
| With diet | 0.433 (0.205 to 0.661) | 47 | 0.608 (0.294 to 0.922) | 38 | 0.296 (0.106 to 0.485) | 204 | 0.761 (0.465 to 1.056) | 39 |
| No diet | 0.255 (0.099 to 0.412) | 42 | 0.452 (0.257 to 0.648) | 40 | 0.464 (0.273 to 0.655) | 23 | 0.562 (0.333 to 0.792) | 36 |
|
| ||||||||
| Exercise time (min/wk) | ||||||||
| <60 | 0.899 (0.335 to 1.463) | 5 | 0.075 (−0.855 to 1.005) | 1 | 0.995 (−0.457 to 2.446) | 2 | 0.771 (0.242 to 1.300) | 3 |
| 60–89 | 0.002 (−0.255 to 0.258) | 5 | 0.360 (−0.433 to 1.153) | 3 | 0.000 (−0.881 to 0.881) | 1 | 0.089 (−0.179 to 0.358) | 4 |
| 90–119 | 0.154 (−0.081 to 0.389) | 10 | 0.391 (0.006 to 0.777) | 9 | 0.193 (−0.763 to 1.148) | 1 | 0.315 (0.034 to 0.595) | 7 |
| 120–149 | 0.373 (0.091 to 0.656) | 17 | 0.615 (0.283 to 0.947) | 14 | 0.293 (0.110 to 0.475) | 4 | 0.976 (0.472 to 1.480) | 9 |
| 150–179 | 0.052 (−0.194 to 0.298) | 7 | 0.243 (0.075 to 0.411) | 8 | 0.200 (−0.051 to 0.450) | 8 | 0.476 (0.234 to 0.718) | 7 |
| 180–209 | 0.208 (−0.045 to 0.460) | 13 | 0.257 (−0.003 to 0.517) | 13 | 0.498 (0.125 to 0.871) | 8 | 0.362 (−0.027 to 0.750) | 13 |
| 210–239 | 0.092 (−0.889 to 1.072) | 1 | 0.063 (−0.917 to 1.043) | 1 | - | - | - | - |
| 240 | 0.303 (−0.206 to 0.811) | 1 | 0.283 (−0.042 to 0.608) | 3 | 0.450 (0.104 to 0.796) | 3 | 0.331 (−0.178 to 0.840) | 1 |
| 300 | 1.237 (0.464 to 2.009) | 6 | 1.643 (0.795 to 2.490) | 6 | 1.309 (0.753 to 1.866) | 3 | 2.290 (1.311 to 3.268) | 6 |
| 420–450 | 0.078 (−0.334 to 0.491) | 2 | 0.103 (−0.310 to 0.515) | 2 | - | - | −0.288 (−0.752 to 0.177) | 1 |
|
| ||||||||
| Duration (wk) | ||||||||
| ≤4 | −0.028 (−0.408 to 0.353) | 3 | 0.017 (−0.893 to 0.928) | 1 | - | - | 0.087 (−0.386 to 0.560) | 1 |
| 8–11 | 0.237 (0.032 to 0.441) | 12 | 0.322 (0.104 to 0.540) | 13 | 0.655 (0.390 to 0.921) | 9 | 0.706 (0.226 to 1.186) | 7 |
| 12–15 | 0.455 (0.179 to 0.731) | 43 | 0.911 (0.501 to 1.322) | 33 | 0.541 (0.216 to 0.866) | 16 | 0.910 (0.573 to 1.246) | 41 |
| 16–19 | 0.576 (0.266 to 0.886) | 13 | 0.431 (0.169 to 0.694) | 10 | 0.411 (−0.041 to 0.864) | 6 | 0.600 (0.242 to 0.959) | 11 |
| 20–23 | 0.114 (−0.085 to 0.313) | 11 | 0.150 (−0.047 to 0.348) | 10 | 0.235 (−0.052 to 0.522) | 9 | 0.143 (−0.085 to 0.372) | 9 |
| 24 | 0.120 (−0.499 to 0.738) | 3 | 0.096 (−0.556 to 0.748) | 3 | - | - | 0.117 (−0.230 to 0.464) | 1 |
| 36 | - | - | 0.642 (0.240 to 1.045) | 1 | - | - | - | - |
| 48 | 0.129 (−0.059 to 0.318) | 2 | 0.214 (0.078 to 0.352) | 6 | 0.209 (0.071 to 0.347) | 6 | 0.284 (0.138 to 0.430) | 4 |
|
| ||||||||
| Intensity | ||||||||
| Low | 0.533 (0.022 to 1.044) | 11 | 0.609 (0.079 to 1.140) | 7 | 0.043 (−0.322 to 0.407) | 5 | 0.558 (−0.446 to 1.562) | 4 |
| Moderate | 0.346 (0.165 to 0.526) | 28 | 0.627 (0.386 to 0.868) | 31 | 0.457 (0.181 to 0.733) | 16 | 0.874 (0.566 to 1.182) | 27 |
| Vigorous | 0.293 (0.136 to 0.450) | 28 | 0.370 (0.184 to 0.557) | 23 | 0.345 (0.189 to 0.501) | 21 | 0.613 (0.387 to 0.838) | 27 |
Meta-ANOVA, meta-analysis of variance; BMI, body mass index; SMD, standardized mean difference; CI, confidence interval; n, number of studies.
Meta-ANOVA results for the effect of exercise on lipid profile variables
| Moderator | TC | TG | LDL | HDL | ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
| SMD (95% CI) | n | SMD (95% CI) | n | SMD (95% CI) | n | SMD (95% CI) | n | |
| Diet control | ||||||||
| With diet | 0.825 (0.050 to 1.601) | 22 | 0.772 (0.184 to 1.359) | 25 | 0.340 (0.092 to 0.588) | 27 | −0.116 (−0.549 to 0.317) | 29 |
| No diet | 0.449 (0.172 to 0.727) | 13 | 0.377 (0.114 to 0.641) | 31 | 0.468 (0.259 to 0.677) | 22 | −0.318 (−0.611 to −0.024) | 28 |
|
| ||||||||
| Time (min/wk) | ||||||||
| <60 | −0.019 (−0.949 to 0.911) | 1 | 1.509 (−0.031 to 3.049) | 3 | 0.232 (−0.404 to 0.869) | 2 | (−2..441 (−4.439 to (−0.443) | 4 |
| 60–89 | (−0.044 (−0.677 to 0.589) | 1 | (−0.281 (−0.918 to 0.355) | 1 | (−0.076 (−0.709 to 0.558) | 1 | 0.220 (−0.415 to 0.855) | 1 |
| 90–119 | 0.421 (0.023 to 0.819) | 5 | (−0.131 (−0.468 to 0.206) | 5 | 0.274 (−0.081 to 0.628) | 5 | 0.443 (0.100 to 0.786) | 5 |
| 120–149 | 0.656 (0.028 to 1.284) | 6 | 0.709 (0.109 to 1.308) | 12 | 0.578 (0.100 to 1.056) | 10 | (−0.506 (−1.075 to 0.063) | 12 |
| 150–179 | 0.040 (−0.215 to 0.294) | 5 | (−0.195 (−0.550 to 0.159) | 6 | 0.028 (−0.215 to 0.271) | 6 | (−0.179 (−0.436 to 0.080) | 6 |
| 180–209 | 1.010 (0.641 to 1.558) | 3 | 0.193 (−0.384 to 0.769) | 4 | 0.527 (0.096 to 0.958) | 3 | (−0.359 (−0.667 to (−0.050) | 5 |
| 210–239 | 1.733 (0.562 to 2.904) | 1 | 0.141 (−0.841 to 1.122) | 1 | 0.406 (−0.586 to 1.397) | 1 | 0.495 (0.502 to 1.492) | 1 |
| 240 | 0.575 (0.144 to 1.005) | 2 | 0.634 (0.202 to 1.066) | 2 | 1.164 (0.706 to 1.623) | 2 | (−1.020 ( (−1.631 to (−0.409) | 2 |
| 300 | - | - | 0.904 (0.040 to 1.769) | 6 | 0.876 (0.350 to 1.401) | 3 | 0.173 (−0.324 to 0.669) | 3 |
| 420–450 | (−0.585 (−1.519 to 0.350) | 1 | (−0.016 (−0.927 to 0.895) | 1 | (−0.548 ( (−1.480 to 0.383) | 1 | 0.505 (−0.423 to 1.434) | 1 |
|
| ||||||||
| Duration (wk) | ||||||||
| ≤4 | (−0.585 (−1.519 to 0.350) | 1 | 0.012 (−0.628 to 0.653) | 2 | (−0.301 (−0.949 to 0.346) | 2 | 0.083 (−0.734 to 0.899) | 2 |
| 8–11 | 0.332 (−0.235 to 0.898) | 3 | 0.274 (−0.105 to 0.652) | 6 | 0.484 (0.105 to 0.862) | 7 | (−0.452 (−0.807 to (−0.100) | 7 |
| 12–15 | 1.165 (−0.116 to 2.447) | 13 | 0.834 (0.161 to 1.507) | 26 | 0.515 (0.249 to 0.780) | 20 | 0.007 (−0.460 to 0.474) | 24 |
| 16–19 | 0.837 (0.465 to 1.209) | 8 | 0.643 (0.150 to 1.136) | 12 | 0.292 (0.048 to 0.535) | 10 | (−0.575 (−1.212 to 0.063) | 14 |
| 20–23 | (−0.058 (−0.322 to 0.205) | 5 | (−0.276 (−0.541 to (−0.011) | 5 | (−0.076 (−0.339 to 0.187) | 5 | 0.154 (−0.110 to 0.417) | 5 |
| 24 | 0.096 (−0.251 to 0.443) | 1 | (−0.014 (−0.361 to 0.333) | 1 | 0.079 (−0.268 to 0.426) | 1 | 0.005 (−0.291 to 0.402) | 1 |
| 36 | 1.492 (1.047 to 1.937) | 1 | 2.585 (2.049 to 3.121) | 1 | 1.402 (0.963 to 1.842) | 1 | (−0.993 (−1.410 to (−0.577) | 1 |
| 48 | 0.575 (0.144 to 1.005) | 2 | 0.634 (0.202 to 1.066) | 2 | 1.164 (0.706 to 1.623) | 2 | (−1.020 (−1.631 to (−0.409) | 2 |
|
| ||||||||
| Intensity | ||||||||
| Low | - | - | 1.191 (0.376 to 2.006) | 6 | 0.894 (0.076 to 1.711) | 3 | (−1.675 (−3.175 to (−0.175) | 6 |
| Moderate | 0.505 (0.188 to 0.822) | 17 | 0.294 (−0.159 to 0.747) | 20 | 0.506 (0.225 to 0.787) | 20 | (−0.023 (−.0358 to 0.313) | 22 |
| Vigorous | 0.124 (−0.081 to 0.330) | 13 | 0.410 (0.171 to 0.649) | 22 | 0.176 (−0.057 to 0.409) | 20 | (−0.285 (−0.513 to (−0.057) | 21 |
Meta-ANOVA, meta-analysis of variance; TC, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SMD, standardized mean difference; CI, confidence interval; n, number of studies.
Figure 2Forest plot of % body fat by exercise time (minutes per week). The average standardized mean difference (SMD) for exercise time per week did not yield a specific pattern as the exercise time increased, possibly because of the small number of studies. “Total” in the figure indicates the number of subjects. Sixteen articles had several (2–5 pieces) comparisons, and each comparison was presented independently in the plot. SD, standard deviation; CI, confidence interval.